Sham/placebo

DRUG4 trials

Sponsors

Nova Southeastern University, University of North Carolina, Chapel Hill

Conditions

Alcohol Use DisorderCigarette SmokingNicotine AddictionTobacco Use DisorderVisual Function

Phase 2

Semaglutide for Alcohol Use Disorder

CompletedNCT05520775

University of North Carolina, Chapel HillAlcohol Use Disorder, Cigarette Smoking

Start: 2022-09-02End: 2024-04-19Updated: 2025-04-02

Effects of Semaglutide on Nicotine Intake

CompletedNCT05530577

University of North Carolina, Chapel HillNicotine Addiction, Tobacco Use Disorder

Start: 2022-10-07End: 2024-05-13Updated: 2025-08-22

Unknown Phase

Effect of Cranial Osteopathy on Visual Function

CompletedNCT00510562

Nova Southeastern UniversityVisual Function

Start: 2001-10-31End: 2002-02-28Updated: 2013-04-04

Effect of Osteopathic Cranial Manipulative Medicine on Visual Function

CompletedNCT02728713

Nova Southeastern UniversityVisual Function

Start: 2003-08-31End: 2005-11-30Updated: 2016-04-05

Related Papers

Once-Weekly Semaglutide in Adults With Daily Cigarette Use

JAMA Network Open2026-05-26

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder

UNC Libraries2025-03-04

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder

JAMA Psychiatry2025-02-12107 citations

Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder

Addiction Science & Clinical Practice2024-07-276 citations

2017 Research Conference Abstracts and Poster Competition

Journal of Osteopathic Medicine2016-11-018 citations